Transplantation tolerance: Memories that haunt us

Science Translational Medicine

Volumn 3, Issue 86, 2011, Pages

  Ford, Mandy L ^a   Larsen, Christian P ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ANTIGEN RECOGNITION; ANTIGENICITY; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; CROSS REACTION; DONOR SELECTION; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REVIEW; TRANSLATIONAL RESEARCH; TRANSPLANTATION TOLERANCE; ANIMAL; BONE MARROW TRANSPLANTATION; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; MALE; NOTE; T LYMPHOCYTE;

ANIMALS; BONE MARROW TRANSPLANTATION; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; MALE; T-LYMPHOCYTES;

EID: 79958206918     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3002504     Document Type: Review

References (31)

1. M. Sykes, G. L. Szot, K. A. Swenson, D. A. Pearson, Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat. Med. 3, 783-787 (1997).
2. M. M. Durham, A. W. Bingaman, A. B. Adams, J. Ha, S. Y. Waitze, T. C. Pearson, C. P. Larsen, Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J. Immunol. 165, 1-4 (2000).
3. L. S. Kean, A. B. Adams, E. Strobert, R. Hendrix, S. Gangappa, T. R. Jones, N. Shirasugi, M. R. Rigby, K. Hamby, J. Jiang, H. Bello, D. Anderson, K. Cardona, M. M. Durham, T. C. Pearson, C. P. Larsen, Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am. J. Transplant. 7, 320-335 (2007).
4. T. Kawai, H. Sogawa, S. Boskovic, G. Abrahamian, R. N. Smith, S. L. Wee, D. Andrews, O. Nadazdin, I. Koyama, M. Sykes, H. J. Winn, R. B. Colvin, D. H. Sachs, A. B. Cosimi, CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am. J. Transplant. 4, 1391-1398 (2004).
5. T. Kawai, A. B. Cosimi, R. B. Colvin, J. Powelson, J. Eason, T. Kozlowski, M. Sykes, R. Monroy, M. Tanaka, D. H. Sachs, Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59, 256-262 (1995).
6. O. Nadazdin, S. Boskovic, T. Murakami, G. Tocco, R.-N. Smith, R. B. Colvin, D. H. Sachs, J. Allan, J. C. Madsen, T. Kawai, A B. Cosimi, G. Benichou, Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci. Transl. Med. 86, 86ra51 (2011).
7. + T cells throughout life, from newborns to centenarians: Implications for T cell memory. Mech. Ageing Dev. 86, 173-195 (1996).
8. R. Lechler, R. Batchelor, G. Lombardi, The relationship between MHC restricted and allospecific T cell recognition. Immunol. Lett. 29, 41-50 (1991).
9. G. Lombardi, S. Sidhu, M. Daly, J. R. Batchelor, W. Makgoba, R. I. Lechler, Are primary alloresponses truly primary? Int. Immunol. 2, 9-13 (1990).
10. C. Macedo, E. A. Orkis, I. Popescu, B. D. Elinoff, A. Zeevi, R. Shapiro, F. G. Lakkis, D. Metes, Contribution of naïve and memory T-cell populations to the human alloimmune response. Am. J. Transplant. 9, 2057-2066 (2009).
11. A. B. Adams, M. A. Williams, T. R. Jones, N. Shirasugi, M. M. Durham, S. M. Kaech, E. J. Wherry, T. Onami, J. G. Lanier, K. E. Kokko, T. C. Pearson, R. Ahmed, C. P. Larsen, Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111, 1887-1895 (2003).
12. J. P. Pearl, J. Parris, D. A. Hale, S. C. Hoff mann, W. B. Bernstein, K. L. McCoy, S. J. Swanson, R. B. Mannon, M. Roederer, A. D. Kirk, Immunocompetent T-cells with a memorylike phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am. J. Transplant. 5, 465-474 (2005).
13. J. Yang, M. O. Brook, M. Carvalho-Gaspar, J. Zhang, H. E. Ramon, M. H. Sayegh, K. J. Wood, L. A. Turka, N. D. Jones, Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl. Acad. Sci. U.S.A. 104, 19954-19959 (2007).
14. B. Pantenburg, F. Heinzel, L. Das, P. S. Heeger, A. Valujskikh, T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J. Immunol. 169, 3686-3693 (2002).
15. S. R. Burrows, S. L. Silins, D. J. Moss, R. Khanna, I. S. Misko, V. P. Argaet, T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 182, 1703-1715 (1995).
16. A. L. Amir, L. J. D'Orsogna, D. L. Roelen, M. M. van Loenen, R. S. Hagedoorn, R. de Boer, M. A. van der Hoorn, M. G. Kester, I. I. Doxiadis II, J. H. Falkenburg, F. H. Claas, M. H. Heemskerk, Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115, 3146-3157 (2010).
17. N. J. Felix, P. M. Allen, Specificity of T-cell alloreactivity. Nat. Rev. Immunol. 7, 942-953 (2007).
18. T. L. Floyd, B. H. Koehn, W. H. Kitchens, J. M. Robertson, J. A. Cheeseman, L. Stempora, C. P. Larsen, M. L. Ford, Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for costimulation during recall. J. Immunol. 186, 2033-2041 (2011).
19. M. L. Ford, C. P. Larsen, Overcoming the memory barrier in tolerance induction: Molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations. Curr. Opin. Organ Transplant. 15, 405-410 (2010).
20. P. F. Halloran, Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351, 2715-2729 (2004).
21. O. Nadazdin, S. Boskovic, T. Murakami, D. H. O'Connor, R. W. Wiseman, J. A. Karl, J. J. Tuscher, D. H. Sachs, J. C. Madsen, G. Tocco, T. Kawai, A. B. Cosimi, G. Benichou, Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am. J. Transplant. 10, 1375-1384 (2010).
22. T. A. Weaver, A. H. Charafeddine, A. Agarwal, A. P. Turner, M. Russell, F. V. Leopardi, R. L. Kampen, L. Stempora, M. Song, C. P. Larsen, A. D. Kirk, Alefacept promotes costimulation blockade based allograft survival in nonhuman primates. Nat. Med. 15, 746-749 (2009).
23. I. R. Badell, M. C. Russell, P. W. Thompson, A. P. Turner, T. A. Weaver, J. M. Robertson, J. G. Avila, J. A. Cano, B. E. Johnson, M. Song, F. V. Leopardi, S. Swygert, E. A. Strobert, M. L. Ford, A. D. Kirk, C. P. Larsen, LFA-1-specific therapy prolongs allograft survival in rhesus macaques. J. Clin. Invest. 120, 4520-4531 (2010).
24. K. Setoguchi, A. D. Schenk, D. Ishii, Y. Hattori, W. M. Baldwin 3rd, K. Tanabe, R. L. Fairchild, LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am. J. Transplant. 11, 923-935 (2011).
25. C. N. Ellis, G. G. Krueger; Alefacept Clinical Study Group, Treatment of chronic plaque psoriasis by selective targeting of memory eff ector T lymphocytes. N. Engl. J. Med. 345, 248-255 (2001).
26. M. Lebwohl, S. K. Tyring, T. K. Hamilton, D. Toth, S. Glazer, N. H. Tawfik, P. Walicke, W. Dummer, X. Wang, M. R. Garovoy, D. Pariser; Efalizumab Study Group, A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N. Engl. J. Med. 349, 2004-2013 (2003).
27. N. A. Turgeon, J. G. Avila, J. A. Cano, J. J. Hutchinson, I. R. Badell, A. J. Page, A. B. Adams, M. H. Sears, P. H. Bowen, A. D. Kirk, T. C. Pearson, C. P. Larsen, Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am. J. Transplant. 10, 2082-2091 (2010).
28. A. M. Posselt, M. D. Bellin, M. Tavakol, G. L. Szot, L. A. Frassetto, U. Masharani, R. K. Kerlan, L. Fong, F. G. Vincenti, B. J. Hering, J. A. Bluestone, P. G. Stock, Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am. J. Transplant. 10, 1870-1880 (2010).
29. I. R. Ferrer, M. E. Wagener, J. M. Robertson, A. P. Turner, K. Araki, R. Ahmed, A. D. Kirk, C. P. Larsen, M. L. Ford, Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J. Immunol. 185, 2004-2008 (2010).
30. S. C. Jameson, D. Masopust, Diversity in T cell memory: An embarrassment of riches. Immunity 31, 859-871 (2009).
31. Acknowledgment: The authors have no conflicts of interest to disclose. This work was supported by NIH AI073707 and AI40519.